Seagen
New York, NY, USA
ROLE SUMMARY TIVDAK is a treatment for patients with recurrent/metastatic cervical cancer that received FDA approval in September 2021 and launched with our co-promote partner, Genmab. TIVDAK volume and utilization has grown quarter over quarter since its approval and continues to deliver growth in early 2024. This is an exciting opportunity to work on a fast-paced, co-promote with a high performing team and to support patients with advanced cervical cancer. The TIVDAK Team is seeking a highly motivated Director, US Marketing and Alliance Operations. This new role will be responsible for ensuring commercial excellence in project and relationship management (external partnerships and alliances), as well as leading key HCP marketing initiatives. This individual will work collaboratively with key internal and external stakeholders to coordinate, manage, and deliver seamless execution of commercial strategic objectives. The Director will also be accountable for...